Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

LEUPRORELIN CRS (1 MG)

LEUPRORELIN CRS (1 MG)

53714-56-0

DISCOVER
LEUPRORELIN - REFERENCE SPECTRUM (N/A)

LEUPRORELIN - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Lycopsamine

Lycopsamine

10285-07-1

DISCOVER
LEVAMISOLE HYDROCHLORIDE CRS (20 MG)

LEVAMISOLE HYDROCHLORIDE CRS (20 MG)

16595-80-5

DISCOVER
LEVOCABASTINE HYDROCHLORIDE CRS (125 MG)

LEVOCABASTINE HYDROCHLORIDE CRS (125 MG)

79547-78-7

DISCOVER
LEVOCARNITINE CRS (15 MG)

LEVOCARNITINE CRS (15 MG)

541-15-1

DISCOVER
LEVOCARNITINE IMPURITY A CRS (30 MG)

LEVOCARNITINE IMPURITY A CRS (30 MG)

NA

DISCOVER
Levofloxacin D8

Levofloxacin D8

1217716-71-6

DISCOVER
LEVODOPA CRS (20 MG)

LEVODOPA CRS (20 MG)

59-92-7

DISCOVER
Levetiracetam

Levetiracetam

102767-28-2

DISCOVER
LEVODROPROPIZINE CRS (60 MG)

LEVODROPROPIZINE CRS (60 MG)

99291-25-5

DISCOVER
LEVODROPROPIZINE IMPURITY A CRS (25 MG)

LEVODROPROPIZINE IMPURITY A CRS (25 MG)

NA

DISCOVER